# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercializat...
Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the p...
https://www.sec.gov/Archives/edgar/data/1609550/000110465925097180/xslSCHEDULE_13G_X01/primary_doc.xml
UBS analyst Danielle Antalffy downgrades Inspire Medical Systems (NYSE:INSP) from Buy to Neutral and lowers the price target...
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.Mont-Saint-Guibert, Belgium – September 15, 2025,...
Evercore ISI Group analyst Daniel Markowitz initiates coverage on Inspire Medical Systems (NYSE:INSP) with a Outperform rati...
Inspire Medical Systems (NYSE:INSP) affirms FY2025 GAAP EPS guidance from $0.40-$0.50 to $0.40-$0.50 vs $2.27 analyst estimate....